12. Transcriptomics and Cancer Risk Assessment
- Prof. Dr. Günter Obe2,3,
- Dr. Burkhard Jandrig4,
- Prof. Dr. Gary E. Marchant5,
- Dipl. Päd. Holger Schütz6,
- Prof. Dr. Peter M. Wiedemann7
Published Online: 27 APR 2011
DOI: 10.1002/9783527634613.ch12
Copyright © 2011 Wiley-VCH Verlag GmbH & Co. KGaA
Book Title
Cancer Risk Evaluation: Methods and Trends
Additional Information
How to Cite
Kemmner, W. (2011) Transcriptomics and Cancer Risk Assessment, in Cancer Risk Evaluation: Methods and Trends (eds G. Obe, B. Jandrig, G. E. Marchant, H. Schütz and P. M. Wiedemann), Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim, Germany. doi: 10.1002/9783527634613.ch12
Editor Information
- 2
Ret. from University Duisburg-Essen, Germany
- 3
Gershwinstrasse 33, 14513 Teltow, Germany
- 4
Max-Delbrück-Center for Molecular Medicine (MDC), Robert-Rössle-Str. 10, 13125 Berlin, Germany
- 5
Arizona State University, Sandra Day O'Connor College of Law, P.O. Box 877906, Tempe, AZ 85287-796, USA
- 6
Research Center Jülich, Institute of Neuroscience and Medicine (INM-8), 52425 Jülich, Germany
- 7
Karlsruher Institut für Technologie (KIT), TAB – Büro für Technikfolgen-Abschätzung beim Deutschen Bundestag, Neue Schönhauser Straße 10, 10178 Berlin, Germany
Publication History
- Published Online: 27 APR 2011
- Published Print: 20 APR 2011
ISBN Information
Print ISBN: 9783527327539
Online ISBN: 9783527634613
- Summary
- Chapter
- References
Keywords:
- biomarker expression;
- gene expression profiling;
- genesignature;
- microarray analysis;
- Laser microdissection;
- prognosis;
- monitoring
Summary
This chapter contains sections titled:
Introduction
Sample Preparation, Technical Issues, and Data Analysis
Conclusions
References